TCP1 and neoplasm: TCP-1-modified TNVs demonstrated superiority over unmodified TNVs,The modified TNVs can specifically recognize and bind to specific molecules or structures in tumor cells or the tumor microenvironment, thereby increasing the concentration of the drug at the tumor site, enhancing therapeutic effects, and simultaneously reducing damage to normal tissues.